Published in Stat Med on July 01, 1990
Neck pain patients' preference scores for their current health. Qual Life Res (2010) 0.76
A stratified Wilcoxon-type test for trend. Stat Med (1991) 0.75
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73
Tables of the number of patients required in clinical trials using the logrank test. Stat Med (1983) 5.34
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am J Epidemiol (1999) 2.40
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
Injuries sustained on "bouncy castles". BMJ (1992) 2.20
Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer (1979) 1.92
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med (1994) 1.90
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst (1995) 1.84
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med (1986) 1.82
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst (1994) 1.61
Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol (1994) 1.56
Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer (1991) 1.49
The use of a Kolmogorov--Smirnov type statistic in testing hypotheses about seasonal variation. J Epidemiol Community Health (1979) 1.49
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
The future of prognostic factors in outcome prediction for patients with cancer. Cancer (1992) 1.39
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J (Clin Res Ed) (1988) 1.39
Stopping rules for clinical trials incorporating clinical opinion. Biometrics (1984) 1.33
Effect of starvation on the tissue composition of the small intestine in the rat. Am J Physiol (1968) 1.31
Variations in the level of reporting by hospitals to a regional cancer registry. Br J Cancer (1978) 1.29
Randomised comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet (1979) 1.29
Randomized, placebo-controlled, double-blind study of low-dose oral interferon-alpha in HIV-1 antibody positive patients. J Acquir Immune Defic Syndr (1992) 1.27
An assay for dopamine-beta-hydroxylase activity in tissues and serum. Experientia (1971) 1.26
Multivariate analysis of prognostic factors for operable rectal cancer. Lancet (1984) 1.18
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev (1996) 1.15
Monitoring clinical trials: conditional or predictive power? Control Clin Trials (1986) 1.14
Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol (1995) 1.13
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res (1997) 1.11
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer (1987) 1.10
System delay in breast cancer in whites and blacks. Am J Epidemiol (1995) 1.09
Validation of intermediate end points in cancer research. J Natl Cancer Inst (1990) 1.07
Applying Bayesian ideas in drug development and clinical trials. Stat Med (1993) 1.07
Serum dopamine-beta-hydroxylase activity in neuroblastoma. N Engl J Med (1972) 1.05
Improving the quality of data in randomized clinical trials: the COMPACT computer package. COMPACT Steering Committee. Stat Med (1988) 1.03
A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma. Clin Oncol (1978) 1.02
Checking for completeness of 24-h urine collection using para-amino benzoic acid not necessary in the Observing Protein and Energy Nutrition study. Eur J Clin Nutr (2013) 0.99
Energy adjustment methods for nutritional epidemiology: the effect of categorization. Am J Epidemiol (1994) 0.99
Interpretation of energy adjustment models for nutritional epidemiology. Am J Epidemiol (1993) 0.99
Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer (2000) 0.98
Changes in human serum dopamine- -hydroxylase activity with age. Nature (1972) 0.98
Bayesian design and analysis of two x two factorial clinical trials. Biometrics (1997) 0.98
Limitations of mortality data as a guide to comparative lung cancer incidence within an urban area. Public Health (1979) 0.97
Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics (1998) 0.97
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant (2010) 0.97
Measurement error and dietary intake. Adv Exp Med Biol (1998) 0.96
A unified method for monitoring and analysing controlled trials. Stat Med (1994) 0.93
Effect of measurement error on energy-adjustment models in nutritional epidemiology. Am J Epidemiol (1997) 0.92
Dopamine- -hydroxylase activity in mouse neuroblastoma tumors and in cell cultures. Proc Natl Acad Sci U S A (1972) 0.92
A modified approach to estimating sample size for simple logistic regression with one continuous covariate. Stat Med (2010) 0.92
Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin. Oncogene (2009) 0.90
Early stopping of prevention trials when multiple outcomes are of interest: a discussion. Stat Med (1994) 0.90
A radioimmunoassay of human circulatory dopamine-beta-hydroxylase. Life Sci (1973) 0.89
The impact of stopping rules on heterogeneity of results in overviews of clinical trials. Biometrics (1992) 0.89
The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments. Br J Cancer Suppl (1980) 0.89
Serum dopamine-beta-hydroxylase levels in Down's syndrome. Clin Genet (1974) 0.89
A familial study in serum dopamine-beta-hydroxylase levels in torsion dystonia. Neurology (1974) 0.88
Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group. Bone Marrow Transplant (2012) 0.88
Spontaneous regression of a desmoid tumour. J Bone Joint Surg Br (1986) 0.88
Diet and colorectal cancer: still an open question. J Natl Cancer Inst (1995) 0.87
Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol (2003) 0.87
Statistical design of calibration studies. Am J Clin Nutr (1997) 0.87
Seasonal variations in the clinical of presentation of Crohn's disease and ulcerative colitis. Int J Epidemiol (1975) 0.87
Pathology review in cancer research. Br J Cancer (1993) 0.87
The pharmacokinetics of misonidazole in the dog. Eur J Cancer (1979) 0.87
Studies on dopamine-beta-hydroxylase in mental disorders. J Psychiatr Res (1974) 0.85
Serum dopamine-beta-hydroxylase activity in Down's syndrome: a familial study. Res Commun Chem Pathol Pharmacol (1974) 0.85
Surrogate end points in cancer research: a critique. Cancer Epidemiol Biomarkers Prev (1996) 0.84
Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease. Lancet (1972) 0.84
Use of semiquantitative food frequency questionnaires to estimate the distribution of usual intake. Am J Epidemiol (1996) 0.83
Covariate measurement error adjustment for matched case-control studies. Biometrics (2001) 0.83
Register of dietary assessment calibration-validation studies: a status report. Am J Clin Nutr (1997) 0.83
Prognostic factors in metastatic germ cell tumors. Prog Clin Biol Res (1990) 0.83
Reversal of cycloheximide-induced amnesia by adrenergic receptor stimulation. Pharmacol Biochem Behav (1977) 0.82
Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel. Anticancer Res (2000) 0.82
Serum dopamine-beta-hydroxylase in familial dysautonomia. J Lab Clin Med (1975) 0.81
Pulsating electromagnetic fields in the treatment of delayed and non-union of fractures: results from a district general hospital. Injury (1985) 0.80
Malignant melanoma of the anorectal region: two cases of prolonged survival. Br J Surg (1984) 0.80
Sparing of the brain in neonatal undernutrition: amino acid transport and incorporation into brain and muscle. Science (1980) 0.80
Using replicate observations in observer agreement studies with binary assessments. Biometrics (1991) 0.80
A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma. Report to the Medical Research Council by the Brain Tumor Working Party. Int J Radiat Oncol Biol Phys (1989) 0.79
The effect of cold pressor test in man on serum immunoreactive dopamine-beta-hydroxylase and on dopamine-beta-hydroxylase activity. Res Commun Chem Pathol Pharmacol (1973) 0.79
A statistical comparison of different family history scores. Stat Med (2007) 0.79
Effects of cycloheximide, a protein synthesis inhibitor, on mouse brain catecholamine biochemistry. Pharmacol Biochem Behav (1982) 0.79
Adjusting for time trends when estimating the relationship between dietary intake obtained from a food frequency questionnaire and true average intake. Biometrics (1995) 0.78
The inhibition of catecholamine biosynthesis by apomorphine. J Pharm Pharmacol (1970) 0.78
An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise? Cancer Epidemiol Biomarkers Prev (1998) 0.78
What does it mean to be a cancer gene carrier? Problems in establishing causality from the molecular genetics of cancer. J Natl Cancer Inst (1995) 0.77
Meta-analyses of dietary fats and mammary neoplasms in rodent experiments. Breast Cancer Res Treat (1998) 0.77
Intraepithelial and postinvasive neoplasia as a stochastic continuum of clonal evolution, and its relationship to mechanisms of chemopreventive drug action. J Cell Biochem Suppl (1993) 0.77
Urbanicity-related trends in lung cancer mortality in US counties: white females and white males, 1970-1987. Int J Epidemiol (1996) 0.77
Serum dopamine- -hydroxylase (D H) activity and affective states. Psychopharmacologia (1972) 0.77